ProPhase Labs, Inc. (PRPH): Cash & Equivalents
$90.0K
As of 2025-12-31
$20.0K
As of 2026-06-30
-78.5%
3-year compound annual growth
-57.9%
5-year compound annual growth
-25.3%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $90.0K | -86.7% | 2026-06-01, Balance as of period end |
| 2024-12-31 | $678.0K | -57.9% | 2026-06-01, Balance as of period end |
| 2023-12-31 | $1.61M | -82.3% | 2025-04-01, Balance as of period end |
| 2022-12-31 | $9.11M | +8.3% | 2024-03-29, Balance as of period end |
| 2021-12-31 | $8.41M | +23.4% | 2023-03-29, Balance as of period end |
| 2020-12-31 | $6.82M | n/m | 2022-03-31, Balance as of period end |
| 2019-12-31 | $434.0K | -72.1% | 2021-03-31, Balance as of period end |
| 2018-12-31 | $1.55M | -51.0% | 2020-03-26, Balance as of period end |
| 2017-12-31 | $3.17M | +619.5% | 2019-03-26, Balance as of period end |
| 2016-12-31 | $441.0K | -73.5% | 2018-08-20, Balance as of period end |
| 2015-12-31 | $1.66M | -43.1% | 2018-08-20, Balance as of period end |
| 2014-12-31 | $2.93M | +78.6% | 2017-02-24, Balance as of period end |
| 2013-12-31 | $1.64M | +186.4% | 2016-03-29, Balance as of period end |
| 2012-12-31 | $572.0K | -89.7% | 2015-03-27, Balance as of period end |
| 2011-12-31 | $5.54M | -32.7% | 2014-03-27, Balance as of period end |
| 2010-12-31 | $8.23M | -35.7% | 2013-03-28, Balance as of period end |
| 2009-12-31 | $12.80M | n/a | 2012-03-07, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | 2025-12-31 | $90.0K | -86.7% |
| China Pharma Holdings, Inc. (CPHI) | 2025-12-31 | $345.1K | -44.9% |
| CervoMed Inc. (CRVO) | 2025-12-31 | $8.24M | -8.5% |
| Ensysce Biosciences, Inc. (ENSC) | 2025-12-31 | $4.31M | +23.1% |
| Marker Therapeutics, Inc. (MRKR) | 2025-12-31 | $16.07M | -16.3% |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | $109.52M | +71.0% |
| TherapeuticsMD, Inc. (TXMD) | 2024-12-31 | $5.06M | +16.9% |
| Korro Bio, Inc. (KRRO) | 2025-12-31 | $21.82M | -60.8% |
| Upstream Bio, Inc. (UPB) | 2025-12-31 | $101.58M | -68.8% |
Compare PRPH, CPHI, CRVO, ENSC side by side · Screen every company in Pharmaceutical Preparations ↗